Delivery Order SPE2DR25D2005-SPE2DR26FE6C2
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $42,738.51 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of November 5, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,709.46 on August 12, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $25,953.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml quantity). This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 13, 2025. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,323.54 for Dupixent 300 mg/2 ml pen 2ml units on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed price, non-set-aside contract represents a direct purchase under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent...
- The Defense Logistics Agency awarded a delivery order valued at $6,077.05 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $17,561.86 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions such as atopic...
- The Defense Logistics Agency awarded a $18,415.47 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a direct delivery of pharmaceutical products to support federal healthcare operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $17,370.55 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed-price, non-set-aside contract executed under an Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through...
- The Defense Logistics Agency awarded a $27,728.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). The contract, which is a non-set-aside competitive award with an ultimate completion date of June 3, 2025, represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,105.00 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single shipment of pharmaceutical product to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....